A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial
Background: Heavy menstrual bleeding (HMB) is a common problem, yet evidence to inform decisions about initial medical treatment is limited. Objectives: To assess the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system (LNG-IUS) (Mirena®, Bayer) compared...
Main Authors: | Janesh K Gupta, Jane P Daniels, Lee J Middleton, Helen M Pattison, Gail Prileszky, Tracy E Roberts, Sabina Sanghera, Pelham Barton, Richard Gray, Joe Kai |
---|---|
Format: | Article |
Language: | English |
Published: |
NIHR Journals Library
2015-10-01
|
Series: | Health Technology Assessment |
Online Access: | https://doi.org/10.3310/hta19880 |
Similar Items
-
Levonorgestrel-releasing intrauterine system vs. usual medical treatment for menorrhagia: an economic evaluation alongside a randomised controlled trial.
by: Sabina Sanghera, et al.
Published: (2014-01-01) -
A randomized clinical trial to compare levonorgestrel-releasing intrauterine system (Mirena) vs trans-cervical endometrial resection for treatment of menorrhagia
by: Ghazizadeh S, et al.
Published: (2011-07-01) -
Role of the levonorgestrel intrauterine system in effective contraception
by: Attia AM, et al.
Published: (2013-08-01) -
Non-contraceptive applications of the levonorgestrel intrauterine system
by: Maria Isabel Rodriguez, et al.
Published: (2010-04-01) -
Effect of Guizhifuling capsule combined with levonorgestrel releasing intrauterine system on adenomyosis
by: Dong-Tao Shi, et al.
Published: (2016-11-01)